ID: ALA330099

Max Phase: Preclinical

Molecular Formula: C10H17NO5

Molecular Weight: 231.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)C(=O)NC(CC(C)C)C(=O)OC

Standard InChI:  InChI=1S/C10H17NO5/c1-6(2)5-7(9(13)15-3)11-8(12)10(14)16-4/h6-7H,5H2,1-4H3,(H,11,12)

Standard InChI Key:  CWKLZJLKXISRCM-UHFFFAOYSA-N

Associated Targets(non-human)

P4ha1 Prolyl 4-hydroxylase alpha-1 subunit (36 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 231.25Molecular Weight (Monoisotopic): 231.1107AlogP: -0.14#Rotatable Bonds: 4
Polar Surface Area: 81.70Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.46CX Basic pKa: CX LogP: 0.98CX LogD: 0.98
Aromatic Rings: 0Heavy Atoms: 16QED Weighted: 0.54Np Likeness Score: 0.14

References

1. Cunliffe CJ, Franklin TJ, Hales NJ, Hill GB..  (1992)  Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivatives.,  35  (14): [PMID:1321909] [10.1021/jm00092a016]

Source